WHO Study Group on cell substrates for production of biologicals, Geneva, Switzerland, 11–12 June 2007

For many years, the World Health Organization (WHO) has provided global leadership in defining technical specifications for quality assurance and safety of biological medicines produced in cell substrates. Current WHO requirements for the use of animal cells as substrates for production of vaccines and other biologicals were adopted by the WHO Expert Committee on Biological Standardization in 1996 (WHO TRS 878). Since then, significant progress especially in the development of vaccines in novel continuous cell lines of mammalian origin as well as in insect cells has been made and consequently there is an increasing need for the re-evaluation of existing criteria for the acceptability of such cell lines. In addition there is also a need to consider new issues in cell substrate safety arising from these new cell types and developments in technology and scientific knowledge. In response to these demands, the WHO Study Group on Cell Substrates was formed in 2006 to initiate revision of WHO requirements and to address the need for further research in this area. At its second meeting on 11-12 June 2007, the Study Group reviewed scientific data that would form the basis for new recommendations and made a number of proposals for further investigations. The Study Group is working on the preparation of a revised WHO document, and a broad consultation with regulators, manufacturers, and other relevant parties is planned for 2008.     

硝化基质和产物对发光细菌的急性毒性

摘要：【目的】对硝化基质和产物对硝化过程的影响进行初步研究。【方法】采用发光细菌法,在pH=7.0的条件下,测定了氨、羟胺、亚硝酸和硝酸对发光细菌的急性毒性（15min-半抑制浓度（the half inhibitory concentration,IC50））。【结果】单一物质的毒性试验结果表明,硝化基质和产物对发光细菌的毒性随浓度的升高而增大,且具有较好的线性关系;氨、羟胺、亚硝酸和硝酸的IC50分别为2180.2 mg/L、6.2740 mg/L、1207.2 mg/L和3140.3 mg/L;其毒性大小顺序为：羟胺 >亚硝酸 >氨 >硝酸。按等效浓度混合法测定硝化基质和产物的联合毒性,结果表明：氨与羟胺、氨与亚硝酸、羟胺与亚硝酸对发光细菌的联合毒性呈相加作用;氨与硝酸、羟胺与硝酸、亚硝酸与硝酸对发光细菌的联合毒性呈独立作用;氨、羟胺、亚硝酸、硝酸四元混合物的联合毒性也呈相加作用。【结论】根据硝化基质和产物对发光细菌和硝化细菌抑制浓度的相关性,可用发光细菌发光强度的变化指示硝化基质和产物的抑制作用。     

Review: Production, characterization, and testing of banked mammalian cell substrates used to produce biological products

Summary A critical component in controlling the production of biological products derived from human and animal cell lines in the characterization and testing of banked cell substrates. The objective is to confirm the identity, purity, and suitability of these cells for manufacturing use. Quality concerns for biological products derived from cell lines originate from the presence of cellular and adventitious contaminants. Well-characterized cell banks not only permit a consistent source of production cells throughout the life of a product but also decrease the likelihood of contamination by other cell lines and adventitious agents. An important part of qualifying a cell line is choosing the appropriate testing for the presence of adventitious contaminants. The qualification of cell banks includes tests for cell identity and endogenous and adventitious microbial contaminants (bacteria, fungi, mycoplasmas, and viruses). For cells producing recombinant deoxyribonucleic acid-derived products, analysis of the expression construct at the nucleic acid level (genetic stability) is also a primary concern. The strategy for designing a safety-testing program for banked cells should be based on sound scientific principles and current regulatory guidance.     

生物制品原辅料及其质量控制

生物制品原辅料的质量控制是保证产品质量的重要因素,就生物制品原辅料分类及质量控制进行了阐述和归纳,并就国家对生物制品原辅料的质量控制要求进行了探讨。     

Viral vaccines and their manufacturing cell substrates: New trends and designs in modern vaccinology

Vaccination is one of the most effective interventions in global health. The worldwide vaccination programs significantly reduced the number of deaths caused by infectious agents. A successful example was the eradication of smallpox in 1979 after two centuries of vaccination campaigns. Since the first variolation administrations until today, the knowledge on immunology has increased substantially. This knowledge combined with the introduction of cell culture and DNA recombinant technologies revolutionized vaccine design. This review will focus on vaccines against human viral pathogens, recent developments on vaccine design and cell substrates used for their manufacture. While the production of attenuated and inactivated vaccines requires the use of the respective permissible cell substrates, the production of recombinant antigens, virus‐like particles, vectored vaccines and chimeric vaccines requires the use – and often the development – of specific cell lines. Indeed, the development of novel modern viral vaccine designs combined with, the stringent safety requirements for manufacture, and the better understanding on animal cell metabolism and physiology are increasing the awareness on the importance of cell line development and engineering areas. A new era of modern vaccinology is arriving, offering an extensive toolbox to materialize novel and creative ideas in vaccine design and its manufacture.     

地高辛标记探针检测生物制品中残余DNA含量

用地高辛标记探针检测由传代细胞系生产的人用精制狂犬病疫苗,重组（CHO细胞）乙肝疫苗,出血热疫苗及痢疾多糖结合疫苗原液中残余DNA含量。结果表明,该方法特异性强,灵敏度高,可用于上述生物制品中残余DNA含量的检测。     

Evaluation of edible mushroom Oudemansiella canarii cultivation on different lignocellulosic substrates

In this study, the mycelial growth rate, mycelial colonization time, yield, and biological efficiency of the edible mushroom Oudemansiella canarii were determined, and the effects of different substrate combinations on productivity, chemical contents and amino acids were evaluated. Lignocellulosic wastes, such as cottonseed hull, sawdust, corncob, and their combinations supplemented with 18% wheat bran and 2% lime, were used for the cultivation of O. canarii. The biological efficiency (BE) and essential amino acid content of treatment T1, which consisted of 80% cottonseed hull, were the highest among all the tested treatments. Mixtures that included sawdust, such as treatments T2 (80% sawdust), T4 (40% sawdust + 40% cottonseed hull), and T6 (40% sawdust + 40% corncob), exhibited lower yield and BE. Corncob was good for O. canarii production in terms of yield and BE, whereas the mycelial growth rate and colonization time were lower compared to those on other substrates. Comparing the BE, essential amino acids, and other traits of the six treatments, treatment T1 (80% cottonseed hull) was the best formula for O. canarii cultivation and should be extended in the future.     

NucleoCounter—An efficient technique for the determination of cell number and viability in animal cell culture processes

The NucleoCounter is a novel, portable cell counting device based on the principle of fluorescence microscopy. The present work establishes its use with animal cells and checks its reliability, consistency and accuracy in comparison with other cytometric techniques. The main advantages of this technique are its ability to handle a large number of samples with a high degree of precision and its simplicity and specificity in detecting viable cells quantitatively in a heterogeneous culture. The work addresses and overcomes the problems of subjectivity, and some of the inherent sampling errors associated with using the traditional haemocytometer and Trypan Blue exclusion method. NucleoCounter offers reduced intra- and inter-observer variation as well as consistency in repetitive analysis that establishes it as an efficient and highly potential device for at-line monitoring of animal cell processes. Furthermore, since the only manual steps required are sample aspiration and mixing with two reagents, it is feasible that the whole method could be automated and brought on-line for process monitoring and control.     

生物制品专刊序言

生物制品是一类预防、诊断和治疗疫病的特殊制剂。生物制品的研发是融合微生物学、免疫学、分子生物学、细胞学、基因工程及发酵工艺等学科知识的综合技术体现。生物制品产业是整个生物技术产业的核心和热点。近年来,我国在生物制品研发方面取得了较大进步,为促进我国生物制品研究的交流,本期“生物制品”专刊集中展现了我国生物制品研究人员在预防生物制品、诊断制品、治疗生物制品领域所取得的最新进展。     

An evaluation of artificial substrates for sampling macrobenthos in reservoirs

Artificial substrates were compared with a Ponar grab for sampling benthic macroinvertebrates in Lake Anna, Louisa Co., Virginia. The objective was t0 find which technique was best for assessment 0f thermal effluent effects using the following criteria: 1) provide reliable data on density and composition 0f the macrobenthos with a reasonable number 0f replicates; 2) collect the most taxa; and, 3) require the least amount 0f time. Leaves, 3M Corporation's #200 conservation web, and limestone rocks were compared. Each material was tested separately in chicken wire baskets placed 0n the bottom at several depths. Three replicates of each type were retrieved monthly from each depth using SCUBA and cloth flour sacks and compared with grab samples taken from the same depths. Lesser amounts of these materials were tested separately in smaller plastic containers. All large artificial substrate samplers collected significantly more individuals (P = 0.05) and taxa than the Ponar grab. Small web and leaf samplers best met all three 0f the established criteria. The SCUBA system developed in the study is a fast and reliable sampling method.     

Three-dimensional discrete element method for the prediction of protoplasmic seepage through membrane in a biological cell

This paper presents a three-dimensional and compressible biological cell model based on discrete element method using multiple interacting agent that represent cellular structures within a simulated environment. The cytoplasm and nucleoplasm fluid behavior in the cell is time dependent. When taking this approach, it is important to calibrate protoplasmic flow behaviors through simulation techniques such as compressing the cell and examining the agents representing the cell cytoplasm seeping between the ones representing the confining cell membrane. This type of modelling may motivate future work on simulating simultaneous operations and interactions of multiple cellular agents in an attempt to re-create and predict the appearance of complex phenomena such as protoplasmic seepage that is caused by the force actuations of neighboring cells. Seepage occurs when a cytoplasm agent passes between three membrane particles connected in a triangular network. Based on the force–deformation response of spheres having variable size and stiffness, semi-analytic expressions are developed for the force required to cause seepage and solved numerically to find the maximum resistance offered by the membrane against cytoplasm seepage. The equations are based on force equilibrium and the constitutive relations for particle contact and membrane stiffness. In multi-particle representations of an individual cell undergoing deformation, different modes of cytoplasm seepage through confining cell membranes can occur. This can be avoided if simple criteria are satisfied. These findings can lead to certain fundamental laws for the improvement of novel cell-to-organ simulation techniques based on discrete element method.     

An overview of viral and viral-like agents in cell culture systems

The first recognition of seriously contaminated biological products occurred almost 100 years ago. More recently, in the second half of this century, the potential for contamination by viral and viral-like agents became obvious when the SV-40 virus was identified as an endogenous agent in the cell cultures used to produce polio vaccines. The history of major contamination incidents is reviewed, and current issues are discussed. This revised version was published online in August 2006 with corrections to the Cover Date.     

Uncovering new substrates for Aurora A kinase

Aurora A is a serine/threonine kinase that is essential for a wide variety of cell-cycle-related events, but only a small number of its substrates are known. We present and validate a strategy by which to identify Aurora A substrates and their phosphorylation sites. We developed a computational approach integrating various types of biological information to generate a list of 90 potential Aurora substrates, with a prediction accuracy of about 80%. We also demonstrated the specific phosphorylation of NUSAP (nucleolar and spindle-associated protein) by Aurora A in vivo. Our results provide a means by which to develop an understanding of Aurora A function and suggest unexpected roles for this kinase.     

复杂天然产物合成人工生物系统的设计与构建

天然产物是人类疾病预防和治疗药物的最重要来源。合成生物学技术的蓬勃发展为天然产物的开发注入了全新的活力。文中重点介绍了如何利用合成生物技术进行复杂天然产物合成人工生物系统的设计与构建,包括与此相关的生物元件理性设计、生物元件挖掘、途径装配与集成,模块的组装与系统的适配等内容。     

In vitro cell-based assays for evaluation of antioxidant potential of plant-derived products

Several plant-derived compounds have been screened by antioxidant assays, but many of these results are questionable, since they do not evaluate the pharmacologic parameters. In fact, the development of better antioxidants stills a great challenge. In vitro cell-based assays have been employed to assess the antioxidant effect of various compounds at subcellular level. Cell-based assays can also reveal compounds able to enhance the antioxidant pathways, but without direct radical scavenging action (which could not be detected by traditional assays). These methodologies are general of easy implementation and reproducible making them suitable for the early stages of drug discovery. Hydrogen peroxide, a nonradical derivative of oxygen, can be employed as an oxidative agent in these assays due its biochemical properties (presence of all biological systems, solubility) and capacity to induce cell death. Truthfully, if their limitations are understood (such as difference on cell metabolism when in in vitro conditions), these cell-based assays can provide useful information about the pathways involved in the protective effects of phytochemicals against cell death induced by oxidative stress, which can be exploited to develop new therapeutic approaches.     

An improved method for evaluating hardwood animal bedding products

Technological improvements have led to the development of higher quality hardwood bedding products with lower dust content. Nevertheless, testing procedures used to evaluate the quality of laboratory animal bedding products have not kept pace, resulting in the continued use of flawed and outdated test methods. The present study was conducted to develop an improved method for evaluating the quality of hardwood animal bedding products.     

Exploitation of biological wastes for the production of value-added products under solid-state fermentation conditions

Biological wastes contain several reusable substances of high value such as soluble sugars and fibre. Direct disposal of such wastes to soil or landfill causes serious environmental problems. Thus, the development of potential value-added processes for these wastes is highly attractive. These biological wastes can be used as support-substrates in solid-state fermentation (SSF) to produce industrially relevant metabolites with great economical advantage. In addition, it is an environmentally friendly method of waste management. This paper reviews the reutilization of biological wastes for the production of value-added products using the SSF technique.     

Susceptibility of cell substrates to PrPSc infection and safety control measures related to biological and biotherapeutical products

Concerns over the potential for infectious prion proteins to contaminate human biologics and biotherapeutics have been raised from time to time. Transmission of the pathogenic form of prion protein (PrPSc) through veterinary vaccines has been observed, yet no human case through the use of vaccine products has been reported. However, iatrogenic transmissions of PrPSc in humans through blood components, tissues, and growth hormone have been reported. These findings underscore the importance of reliable detection or diagnostic methods to prevent the transmission of prion diseases, given that the number of asymptomatic infected individuals remains unknown, the perceived incubation time for human prion diseases could be decades, and no cure of the diseases has been found yet. A variety of biochemical and molecular methods can selectively concentrate PrPSc to facilitate its detection in tissues and cells. Furthermore, some methods routinely used in the manufacturing process of biological products have been found to be effective in reducing PrPSc from the products. Questions remain unanswered as to the validation criteria of these methods, the minimal infectious dose of the PrPSc required to cause infection and the susceptibility of cells used in gene therapy or the manufacturing process of biological products to PrPSc infections. Here, we discuss some of these challenging issues.